Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
Pooja Middha(German Cancer Research Center), Jonine D. Figueroa, Volker Arndt(German Cancer Research Center), Angela Cox, Zomoroda Abu‐Ful(Carmel Medical Center), Hiltrud Brauch(German Cancer Research Center), A. Heather Eliassen(Brigham and Women's Hospital), Nilanjan Chatterjee(Johns Hopkins University), Thomas Brüning(Institute for Prevention and Occupational Medicine), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Jose E. Castelao(Servicio Gallego de Salud), Simon S. Cross(University of Sheffield), H. Shelton Earp(University of North Carolina at Chapel Hill), Heiko Becher(Universität Hamburg), Joe Dennis(University of Cambridge), James Y. Dai(Fred Hutch Cancer Center), Mikael Eriksson(Herlev Hospital), Kamila Czene(Karolinska Institutet), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Arif B. Ekici(University Medical Center Groningen), Thomas U. Ahearn(Harvard University), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Leslie Bernstein(National Cancer Institute), Nasim Mavaddat(MRC Epidemiology Unit), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Christine L. Clarke(Memorial University of Newfoundland), Parichoy Pal Choudhury(American Cancer Society), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brian D. Carter(American Cancer Society), Daniele Campa(University of Pisa), Audrey Jung(German Cancer Research Center), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Ãngel Carracedo(Center for Research in Molecular Medicine and Chronic Diseases), Hoda Anton‐Culver(University of California, Irvine), Laura E. Beane Freeman(National Cancer Institute), D. Gareth Evans(Manchester Academic Health Science Centre), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Qin Wang(University of Cambridge), Sara Lindström(University of Washington), Alicia Beeghly‐Fadiel(University of Helsinki), Matthias W. Beckmann, Federico Canzian(German Cancer Research Center), Manjeet K. Bolla(University of Cambridge), Qiuyin Cai(Vanderbilt University)
Cited by 74
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k